# Sarepta Therapeutics, Inc.: Form 8-K, filed Jan 8, 2024

- Company: [Sarepta Therapeutics, Inc.](/companies/srpt.md) (CIK 873303)
- Form: 8-K
- Filed: 2024-01-08
- Accepted by EDGAR: Jan 8, 2024, 12:08 ET
- Period: 2024-01-08
- Accession: 0000950170-24-002822
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/873303/000095017024002822/srpt-20240108.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/873303/000095017024002822/

## Items reported

- Item 2.02: Results of operations
- Item 7.01: Regulation FD disclosure
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/873303/000095017024002822/srpt-20240108.htm

Filed Jan 8, 2024.
Source: SEC EDGAR, the filing index for accession 0000950170-24-002822. Last ingested by Listed: Oct 24, 2026, 14:58 ET. No prices; not investment advice.